Bristol-Myers Squibb Company
0R1F.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$147.02B
Close$
$152.53
109.8% upside
Current Fair Value
109.8% upsideUndervalued by 109.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $147.02 Billion |
|---|---|
| Enterprise Value | $181.41 Billion |
| Dividend Yield | $2.51 (4.26%) |
| Earnings per Share | $3.86 |
| Beta | 0.35 |
| Outstanding Shares | 2,022,241,086 |
Return
| Return on Equity | 41.59% |
|---|---|
| Return on Assets | 10.59% |
| Return on Invested Capital | 17.75% |
Valuation & Multiples
| P/E Ratio | 13.02 |
|---|---|
| PEG | 8.5 |
| Price to Sales | 3.03 |
| Price to Book Ratio | 6.61 |
| Enterprise Value to Revenue | 3.69 |
| Enterprise Value to EBIT | 14.82 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 1.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$11.74 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$1.73
Average shareholder expectationRevenue Estimate
$12.66 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bristol-Myers Squibb Co.
30,250 employees
CEO: Giovanni Caforio Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.